|
US6849425B1
|
|
Methods of optimizing antibody variable region binding affinity
|
|
US6531580B1
|
|
Anti-αvβ3 recombinant human antibodies and nucleic acids encoding same
|
|
AU9796698A
|
|
Method for identifying optimal binding ligands to a receptor
|
|
AU8691398A
|
|
Methods for identifying ligand specific binding molecules
|
|
AU8143798A
|
|
Peptide inhibitors of alpha v beta3 and alpha v beta5
|
|
US6596850B1
|
|
Anti-αv3β3 recombinant human antibodies, nucleic acids encoding same
|
|
US2001016645A1
|
|
Anti-αvβ3 recombinant human antibodies, nucleic acids encoding same
|
|
US5862514A
|
|
Method and means for synthesis-based simulation of chemicals having biological functions
|
|
CA2237398A1
|
|
Tumor associated internalizing antigens and methods for targeting therapeutic agents
|
|
US6331431B1
|
|
Vacuum device and method for isolating periplasmic fraction from cells
|
|
US6348194B1
|
|
Tumor specific internalizing antigens and methods for targeting therapeutic agents
|
|
US5780426A
|
|
Fivemer cyclic peptide inhibitors of diseases involving αv β3
|
|
US5767071A
|
|
Sevenmer cyclic peptide inhibitors of diseases involving αv β3
|
|
US5698426A
|
|
Surface expression libraries of heteromeric receptors
|
|
US5763192A
|
|
Process for obtaining DNA, RNA, peptides, polypeptides, or protein, by recombinant DNA technique
|
|
US5770434A
|
|
Soluble peptides having constrained, secondary conformation in solution and method of making same
|
|
AU2287595A
|
|
Class i peptide binding motifs
|
|
US6258530B1
|
|
Surface expression libraries of randomized peptides
|
|
US5871974A
|
|
Surface expression libraries of heteromeric receptors
|
|
WO9411496A1
|
|
Soluble peptides having constrained, secondary conformation in solution and method of making same
|
